Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 5Head & Neck 4Thoracic 3Lymphoid 3Breast 3Other hematologic neoplasm 2Gynecologic 2Plasma cell 1Other neoplasm 1Myeloid 1Genitourinary 1

Conditions

Lung Neoplasms 3Small Cell Lung Carcinoma 1Pain, Postoperative 1Chronic Pain 1Carcinoma, Small Cell 1Acute Pain 1

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Epinephrine × Thoracic × Clear all
NCT03554473 2025-05-09

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
37 enrolled 19 charts
Thoracic

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT05672394 2023-01-05

US-Guided Serratus Anterior Plane Block Versus Thoracic Epidural in Patients Undergoing Thoracotomy

National Cancer Institute, Egypt

Phase NA Completed
74 enrolled
Thoracic

Lung Neoplasms, Chronic Pain, Acute Pain

NCT03560362 2018-06-20

Postoperative Pain Control With Lipossomic Extended Release Bupivacaine

University of Tennessee

Phase 1/2 Unknown
50 enrolled
Thoracic

Lung Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡